Published in Ann Neurol on January 01, 2003
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2006) 7.32
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med (2006) 5.20
Guidelines for the evaluation and management of status epilepticus. Neurocrit Care (2012) 5.00
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS (2004) 4.64
Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci (2003) 4.06
Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol (2015) 3.84
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study. Clin Infect Dis (2005) 3.47
The circulatory-respiratory determination of death in organ donation. Crit Care Med (2010) 3.02
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology (2013) 3.02
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg (2010) 2.94
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS (2009) 2.88
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology (2006) 2.58
Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol (2010) 2.48
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. J Infect Dis (2005) 2.43
Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42
Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol (2006) 2.27
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol (2011) 2.19
Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav (2003) 2.19
Risk stratification for the in-hospital mortality in subarachnoid hemorrhage: the HAIR score. Neurocrit Care (2014) 2.05
The history of cerebral PET scanning: from physiology to cutting-edge technology. Neurology (2013) 2.04
Procaine spinal neurotoxicity. Anesthesiology (2008) 2.02
Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke (2005) 2.00
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS (2011) 1.90
Cognitive side effects of antiepileptic drugs. Epilepsy Behav (2004) 1.81
Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy. Epilepsia (2014) 1.81
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry (2010) 1.73
The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol (2003) 1.70
Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: one-year outcomes and lessons learned. Crit Care Med (2003) 1.68
Stress-induced cardiomyopathy. Crit Care Med (2015) 1.65
Management of rabies in humans. Clin Infect Dis (2002) 1.64
HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery (2008) 1.63
Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med (2009) 1.63
Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol (2004) 1.63
Consciousness as a useful concept in epilepsy classification. Epilepsia (2014) 1.63
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57
Clinical validation of the NeuroScreen. J Neurovirol (2005) 1.57
Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke (2011) 1.54
Peripheral neuropathy in HIV: prevalence and risk factors. AIDS (2011) 1.53
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants. Pharmacogenet Genomics (2012) 1.52
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
Multifactor clinical score and outcome of mechanical ventilation weaning trials: Burns Wean Assessment Program. Am J Crit Care (2010) 1.50
Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease. Mov Disord (2005) 1.47
Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol (2009) 1.45
Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45
The ACNS subcommittee on research terminology for continuous EEG monitoring: proposed standardized terminology for rhythmic and periodic EEG patterns encountered in critically ill patients. J Clin Neurophysiol (2005) 1.43
Giant cell arteritis. Headache (2014) 1.43
Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev (2007) 1.39
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS (2005) 1.39
Pearls in patient selection for deep brain stimulation. Neurologist (2007) 1.37
Acute brain infarcts after spontaneous intracerebral hemorrhage: a diffusion-weighted imaging study. Stroke (2009) 1.36
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol (2007) 1.36
Theta oscillations mediate interaction between prefrontal cortex and medial temporal lobe in human memory. Cereb Cortex (2009) 1.36
Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci (2005) 1.35
Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest (2008) 1.34
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr (2005) 1.32
Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord (2013) 1.31
Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiatry (2010) 1.28
HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients. PLoS One (2013) 1.27
Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? Arch Neurol (2005) 1.27
Narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Intern Med (2011) 1.27
Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol (2011) 1.26
Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke (2009) 1.24
Neural substrates of emotion as revealed by functional magnetic resonance imaging. Cogn Behav Neurol (2004) 1.21
Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications. Curr Neurol Neurosci Rep (2007) 1.20
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother (2010) 1.19
Famous face identification in temporal lobe epilepsy: support for a multimodal integration model of semantic memory. Cortex (2012) 1.18
Cognitive side effects of antiepileptic drugs in children. Neurology (2004) 1.18
Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia (2005) 1.17
Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord (2010) 1.16
Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis. Mult Scler (2003) 1.16
Teratogenicity of antiepileptic medications. Semin Neurol (2008) 1.16
Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage (2009) 1.16
Using voluntary cough to detect penetration and aspiration during oropharyngeal swallowing in patients with Parkinson disease. Chest (2010) 1.16
Determinants of quality of life in epilepsy. Epilepsy Behav (2004) 1.16
Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr (2011) 1.16
The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord (2009) 1.15
Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia (2010) 1.15
Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism Relat Disord (2011) 1.15
Association between symptoms reported in a population questionnaire and future ischemic stroke: the ARIC study. Neuroepidemiology (2004) 1.15
JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis (2011) 1.13
Consensus statement on continuous EEG in critically ill adults and children, part II: personnel, technical specifications, and clinical practice. J Clin Neurophysiol (2015) 1.12
Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. J Stroke Cerebrovasc Dis (2011) 1.12
A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: the Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR). Neuroimage (2009) 1.11
Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations. Mov Disord (2008) 1.09
Micrographia and related deficits in Parkinson's disease: a cross-sectional study. BMJ Open (2012) 1.08
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol (2008) 1.08
Re: Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2013) 1.07
Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest (2013) 1.07
Treatment of status epilepticus: an international survey of experts. Neurocrit Care (2013) 1.06